Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Data And More Data Expected To Drive BTG Towards Triple-Growth Target

This article was originally published in Clinica

Executive Summary

Interventional medicine specialist BTG plc has set its sights high. Its largest franchise, interventional oncology, reported sales of £75.5m ($112m) for fiscal 2015 and the UK company is aiming to at least triple this figure to $300-400m by 2021. With 2016 already upon us, time is ticking by.

Advertisement

Related Content

OUS Approvals Analysis: Expanded CoreValve Indication And Zika IVDs Among August’s CE Marks

Topics

Advertisement
UsernamePublicRestriction

Register

MT103100

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel